semaglutide 15 units A new study conducted by leading researchers across the United States suggests GLP-1s could have a much greater impact beyond obesity. Link in bio How should I manage a

The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health

Numerator has published the best available data on changes in dietary consumption among GLP-1 users (using actual grocery receipts from 2023 but gathered before the 2024 acceleration in script writing)

Gamma-glutamylcysteine: a substrate for glutathione S-transferases

These medications activate GLP1 receptors

In Lilly's latest earnings report, the company said its revenue increased nearly 30% in part because of the "volume-driven growth from Mounjaro." The drug is seen as a potential game changer in the treatment of obesity after it helped people with diabetes who were overweight or obese lose up to 15.7% of their body weight

Physician check-ins remain important